UY34854A - Inhibidores del transporte de glucosa - Google Patents

Inhibidores del transporte de glucosa

Info

Publication number
UY34854A
UY34854A UY0001034854A UY34854A UY34854A UY 34854 A UY34854 A UY 34854A UY 0001034854 A UY0001034854 A UY 0001034854A UY 34854 A UY34854 A UY 34854A UY 34854 A UY34854 A UY 34854A
Authority
UY
Uruguay
Prior art keywords
compounds
inhibitors
glucose transportation
glucose
transportation inhibitors
Prior art date
Application number
UY0001034854A
Other languages
English (en)
Inventor
Dr Knut Eis
Dr Hartmut Rehwinkel
Dr Iring Heisler
Dr Thomas Müller
Dr Stefan Golz
Dr Joachim Telser
Dr Holger Siebeneicher
Dr Bernd Buchmann
Dr Ludwing Zorn
Dr Markus Koppitz
Dr Niels Linder
Dr Melanie Heroult
Dr Roland Neuhaus
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY34854A publication Critical patent/UY34854A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compuestos químicos de fórmula general (I): en donde RA, RB, RC, RD, m, y n tienen los valores que se les asigna en la descripción y en las reivindicaciones, y que inhiben selectivamente y eficazmente al transportador de glucosa 1 (GLUT1); métodos para preparar dichos compuestos;composiciones farmacéuticas y combinaciones que comprenden dichos compuestos; uso de dichos compuestos para fabricar una composición farmacéutica para el tratamiento o profilaxis de una enfermedad; y compuestos intermediarios que son útiles en la preparación de dichos compuestos.
UY0001034854A 2012-06-07 2013-06-07 Inhibidores del transporte de glucosa UY34854A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12171145 2012-06-07

Publications (1)

Publication Number Publication Date
UY34854A true UY34854A (es) 2014-01-31

Family

ID=48570183

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001034854A UY34854A (es) 2012-06-07 2013-06-07 Inhibidores del transporte de glucosa

Country Status (3)

Country Link
AR (1) AR091376A1 (es)
UY (1) UY34854A (es)
WO (1) WO2013182612A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105960401B (zh) 2013-11-18 2018-06-08 瑞士伊兰科动物保健有限公司 吡啶基或嘧啶基化合物
WO2015078799A1 (en) * 2013-11-27 2015-06-04 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
EP3172194A1 (en) * 2014-07-24 2017-05-31 Bayer Pharma Aktiengesellschaft Glucose transport inhibitors
WO2017040545A1 (en) 2015-09-02 2017-03-09 Trevena, Inc. 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
WO2017129558A1 (en) 2016-01-25 2017-08-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting or treating myelopoiesis-driven cardiometabolic diseases and sepsis
WO2017207754A1 (en) * 2016-06-02 2017-12-07 Sanofi Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein
TW201811795A (zh) 2016-08-24 2018-04-01 美商亞闊股份有限公司 胺基－吡咯并嘧啶酮化合物及其用途
BR112019016827A2 (pt) 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
WO2018152286A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
IL292515A (en) * 2019-11-13 2022-06-01 Metabomed Ltd Glucose absorption inhibitors and their uses
WO2022233782A1 (en) 2021-05-03 2022-11-10 Lead Discovery Center Gmbh Composition comprising an inhibitor of mitochondrial transcription

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551428A (en) 1956-02-10 1970-12-29 Ciba Geigy Corp New 1- (or 2-) substituted 4-mercapto-pyrazolo(3,4-d)pyrimidines
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
EP1373247A2 (en) * 2001-03-29 2004-01-02 Tanabe Seiyaku Co., Ltd. Spiroisoquinoline compounds, methods for their preparation and intermediates thereof
US6815444B2 (en) 2002-05-24 2004-11-09 National Health Research Institutes Anti-enterovirus compounds
TW200418835A (en) * 2003-01-24 2004-10-01 Tanabe Seiyaku Co A pyrazolopyrimidine compound and a process for preparing the same
JP5335191B2 (ja) * 2003-08-22 2013-11-06 デンドレオン コーポレイション Ｔｒｐ−ｐ８発現に関連する疾患の処置をするための組成物および方法
GB0326168D0 (en) 2003-11-10 2003-12-17 Arrow Therapeutics Ltd Chemical compounds
RU2006121990A (ru) * 2003-11-21 2007-12-27 Эррэй Биофарма Инк. (Us) Ингибиторы протеинкиназ акт
WO2005117909A2 (en) 2004-04-23 2005-12-15 Exelixis, Inc. Kinase modulators and methods of use
FR2880626B1 (fr) * 2005-01-13 2008-04-18 Aventis Pharma Sa Derives de la purine, compositions les contenant et utilisation
ES2388315T3 (es) 2007-05-04 2012-10-11 Bristol-Myers Squibb Company Agonistas [6,5]-bicíclicos de receptores GPR119 acoplados a la proteína G
EP2597098A1 (en) * 2007-08-08 2013-05-29 Lexicon Pharmaceuticals, Inc. (7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
WO2010106333A1 (en) 2009-03-19 2010-09-23 Medical Research Council Technology Compounds
EP2549863A4 (en) 2010-03-24 2014-01-01 Univ Ohio COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORTATION
GB201015949D0 (en) 2010-09-22 2010-11-03 Medical Res Council Technology Compounds
AU2011313853A1 (en) 2010-10-11 2013-05-02 Auckland Uniservices Limited Substituted benzamides and their uses

Also Published As

Publication number Publication date
WO2013182612A1 (en) 2013-12-12
AR091376A1 (es) 2015-01-28

Similar Documents

Publication Publication Date Title
UY34854A (es) Inhibidores del transporte de glucosa
CU20140068A7 (es) Triazolopiridinas sustituidas
UY35905A (es) Inhibidores del transporte de glucosa
ECSP13013011A (es) Triazolopiridinas
CL2017000287A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas.
DOP2012000150A (es) Triazolopiridinas
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CU20120171A7 (es) Triazolopiridinas sustituidas
UY33598A (es) Imidazopiridazinas sustituidas
ECSP14013231A (es) Imidazopiridazinas sustituidas con amino
CY1119667T1 (el) Υποκατεστημενες ιμιδαζοπυριδαζινες
DOP2016000253A (es) Nuevos compuestos
UY35293A (es) Isotiazoles sustituidos con amino
SV2017005466A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
DOP2016000118A (es) Tienopirimidinas como inhibidores mknk1 y mknk2
CR20120478A (es) COMPUESTOS DEL COMPLEJO DE Fe(III) PARA EL TRATAMIENTO Y PROFILAXIS DE LOS SÍNTOMAS DE DEFICIENCIA DE HIERRO Y LAS ANEMIAS POR DEFICIENCIA DE HIERRO
CR20160016A (es) Pirazolpiridinas sustituidas
UY35602A (es) Compuestos nuevos para el tratamiento del cáncer
CL2015000848A1 (es) Uso de un compuesto de propilmetilfenol, o una composición que lo comprende, para producir una composición farmacéutica y/o nutracéutica para el tratamiento y/o profilaxis de la anemia infecciosa del salmón (isa) (divisional sol. n° 2654-12).
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CR20150092A (es) Derivados de diazepinona útiles para el tratamiento del síndrome x frágil, enfermedad de parkinson o enfermedad del reflujo
CL2011003355A1 (es) Compuestos derivados de alcoxi-carbonil-amino-alquinil-adenosina ; composición farmacéutica que los comprende; uso del compuesto en la preparación de un medicamento útil para tratar enfermedades autoinmunes, inflamatorias, alérgicas, infecciosas entre otras.
CU20130141A7 (es) Triazolopiridinas
UY34630A (es) Imidazopiridazinas sustituidas con amino

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20210602